Autologous Bone Marrow Infusion as an Adjunct in Therapy of Malignant Disease

1. Three patients with lymphosarcomatosis and two with disseminated Hodgkin’s disease were treated with massive doses (super-dosage) of nitrogen mustard (over 1.0 mg./Kg.) given intravenously, followed by the intravenous infusion of autologous bone marrow.

2. Two of the five patients succumbed to infection. The remaining three patients recovered within one month and experienced brief remissions.

3. It is suggested that this form of therapy merits further trial. Thus, it may be considered for use earlier in the course of the disease when there is a smaller total amount of tumor tissue, and thus a greater possibility for its complete eradication. Its use in other neoplastic disorders, as following operative procedures disclosing malignancy, is suggested.